Reply
Arthritis Care Res (Hoboken)
.
2019 May;71(5):696-697.
doi: 10.1002/acr.23558.
Epub 2019 Apr 10.
Authors
Nicolai Leuchten
1
,
George Bertsias
2
,
Josef Smolen
3
,
Thomas Dörner
4
,
Sindhu R Johnson
5
,
Martin Aringer
6
;
SLE Classification Criteria Steering Committee
Affiliations
1
University Medical Center Carl Gustav Carus, and TU Dresden, Dresden, Germany.
2
University of Crete Medical School, Heraklion, Greece.
3
Medical University of Vienna and Hietzing Hospital, Vienna, Austria.
4
Charité University Hospital, Berlin, Germany.
5
Toronto Western Hospital, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
6
University Medical Center Carl Gustav Carus, and TU Dresden, Dresden, Germany On behalf of the SLE Classification Criteria Steering Committee.
PMID:
29579364
DOI:
10.1002/acr.23558
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Antinuclear*
Humans
Lupus Erythematosus, Systemic*
Substances
Antibodies, Antinuclear